Left Atrial Appendage Occlusion and Post-procedural Antithrombotic Management

Area of Science:

• Cardiology
• Medical Devices
• Thrombosis Research

Background:

• Left atrial appendage occlusion (LAAO) offers an alternative to anticoagulation for stroke prevention in atrial fibrillation.
• Post-procedural antithrombotic therapy is standard to mitigate device-related thrombosis (DRT) risk.
• Current antithrombotic strategies following LAAO exhibit significant international and inter-center variability.

Purpose of the Study:

• To review existing evidence on antithrombotic therapy after LAAO.
• To discuss ongoing randomized trials investigating post-procedural management.
• To explore future directions in managing DRT risk.

Main Methods:

• Literature review of current antithrombotic regimens.
• Analysis of data from clinical studies and animal models.
• Overview of ongoing randomized controlled trials.

Main Results:

• The optimal duration and type of antithrombotic therapy post-LAAO are not definitively established.
• DRT risk is highest within the initial 45-90 days post-implantation.
• Variability in clinical practice highlights the need for standardized guidelines.

Conclusions:

• Evidence-based guidelines for post-LAAO antithrombotic therapy are needed.
• Ongoing trials are critical for defining optimal treatment strategies.
• Future research should focus on personalized antithrombotic approaches to minimize DRT.